News

Lygature is pleased to be contributing to an upcoming international workshop titled “Developing New Models for Pharmaceutical Innovation: towards a Mixed Economy,” taking place on Monday, 15 July.

Regulatory sciences make medicines work! This is the conclusion of the recently published article in Clinical Pharmacology & Therapeutics (published online ahead of print). In the article, the Netherlands emerges as a vibrant hub for drug regulatory science, blending national expertise with international collaboration.

The Pediatric Praziquantel Consortium, which Lygature proudly coordinates, has just announced another important milestone.

On 11 June 2024 (13:00-17:15, with drinks and optional dinner afterwards), the Regulatory Science network Netherlands (RSNN) will organize its Annual Workshop. The topic of this year's workshop is 'Artificial Intelligence in Regulatory Innovation'. The workshop will take place in person at Villa Jongerius in Utrecht.

April 7 marks World Health Day 2024, an annual event dedicated to fostering health awareness globally. This year, under the theme “My Health, My Right,” the World Health Organization emphasizes the fundamental principle that everyone deserves access to healthcare, without facing financial hardship.

As we navigate the early months of 2024, the Lygature team has been working hard to foster new and existing collaborations. From engaging in dialogues on antimicrobial resistance (AMR) to leading workshops on the success factors of public-private partnerships, our journey in 2024 so far has been marked by impactful knowledge-sharing exchanges.

This Sunday, 24 March, is World TB Day. As a partner of UNITE4TB, the largest public-private partnership in Tuberculosis (TB) drug development in the history of the European Union, we proudly join the call to action to raise awareness of TB. 

The Dutch National Growth Fund is investing 124.5 million euros in a new centre for animal-free biomedical testing. Of this investment, 55 million euros are awarded directly and 69.5 million euros are granted subject to conditions. Known as the Centre for Animal-Free Biomedical Translation, its aim is to generate safer, more effective treatments, while reducing animal suffering.

In the world of collaborative research, bringing together partners from different sectors and geographies poses unique challenges.

At the start of 2024, EPND partners from Amsterdam UMC and Maastricht University identified five molecular subtypes of Alzheimer’s disease, based on biomarker analyses of cerebrospinal fluid samples available in the EPND catalogue.

Today, 30 January, marks World Neglected Tropical Diseases Day, one of 11 Global Health Days recognized by the World Health Organization (WHO).

Antimicrobial resistance (AMR) presents a worldwide challenge, disproportionately impacting the least developed nations. There is an urgent need to find innovative strategies to expand access to available antibiotics for conditions of high medical need in these geographies.

The Pediatric Praziquantel Consortium, which Lygature proudly coordinates, has announced an important new milestone: The European Medicines Agency (EMA) has adopted a positive scientific opinion of the Consortium’s new pediatric treatment option for preschool-aged children with schistosomiasis.

The European Lead Factory (ELF), a flagship open innovation platform focused on finding high-quality leads for new drug discovery programs, has officially come to a close. 

Lygature is proud to announce that Denis Groot, Finance Director at Lygature, will join the Board of Trustees of EUPATI Europe as treasurer.